Condition: Type 2 Diabetes Mellitus · Metabolic Dysfunction-associated Steatotic Liver Disease · Sponsor: State Key Laboratory of Subhealth Intervention Technology
This study aims to explore the efficacy of CMNT, an intermittent energy restriction (iER) intervention, in managing Chinese adults with type 2 diabetes and non-alcoholic fatty liver disease. An interim analysis will be added to the planned 120-participant CMNT intervention program to compare intervention efficacy with the usual care control group and assess potential risks associated with dietary interventions.
This description comes directly from the study's public registry record.
Wu Luo · +86-0731-8461-5293 · luowubio@163.com
Always discuss trial participation with your own doctor first.
| Physical Examination Center of Gezhouba central hospital of Sinopharm | Yichang, Hubei, China | Recruiting |
| Hunan Shanshui physical examination center | Changsha, Hunan, China | Recruiting |
| Jinheyuan Outpatient Department, National Sub-health Intervention Technology Achievement Application Center | Changsha, Hunan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07083336